Supplement: GOLGI BIOGENESIS AND FUNCTION
Supplement: GOLGI BIOGENESIS AND FUNCTION
批准号:
10580215
负责人:
Yanzhuang Wang
金额:
$13.63万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2024-05-31
关键词:
AddressAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAmericanAmyloid beta-ProteinAmyloid beta-Protein PrecursorBiochemistryBiogenesisBiological AssayCell CycleCell divisionCellsCellular MembraneCellular biologyChimeric ProteinsComplexDefectDevelopmentDiseaseEnsureEventFunctional disorderFundingGORASP2 geneGluesGoalsGolgi ApparatusIn VitroMalignant NeoplasmsMediatingMembraneMembrane FusionMembrane ProteinsMitosisMitoticModelingMolecularMonoubiquitinationNeurodegenerative DisordersOrganellesPathologicPhosphorylationPhysiologicalPost-Translational Protein ProcessingProcessProteinsProteomicsRegulationResearchSorting - Cell MovementStressStructureStructure-Activity RelationshipTechniquesabeta accumulationglycosylationinterdisciplinary approachmutantnovelprotein transportreconstitutionsecretory proteinsyntaxin 5therapeutic targettooltraffickingubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The Golgi apparatus is a central cellular membrane organelle that processes a wide variety of proteins. To
best perform its complex functions, Golgi membranes need to form a unique stacked structure. Notably,
abnormal Golgi fragmentation has been described in an increasing number of diseases that affect millions of
Americans and countless more worldwide, including cancer and neurodegenerative diseases. Despite this, how
the Golgi forms this stacked structure under physiological conditions and how it becomes defective in diseases
remain largely unknown. Over the last few years, we have developed a multidisciplinary approach employing
biochemistry, cell biology, proteomics and glycomics, in combination with a novel in vitro reconstitution assay, to
address these fundamental questions. We found that the Golgi stacking proteins GRASP55 and GRASP65 both
form trans-oligomers to “glue” the Golgi cisternae into stacks. Using GRASPs as tools to manipulate Golgi stack
formation, we provided the first evidence that Golgi stacking impedes protein trafficking to ensure accurate
glycosylation and sorting. During cell division, the Golgi undergoes a disassembly and reassembly process,
which is regulated by phosphorylation that controls cisternal stacking through GRASPs and by
monoubiquitination that regulates p97/p47-mediated post-mitotic Golgi membrane fusion. We identified HACE1,
syntaxin 5, and VCIP135 as the ubiquitin ligase, substrate, and deubiquitinase, respectively, in the latter process.
In Alzheimer’s disease (AD), we found that beta-amyloid (Aβ) accumulation activates Cdk5, which
phosphorylates GRASP65 and causes Golgi fragmentation. Significantly, rescue of Golgi structure by expressing
a phosphorylation deficient mutant of GRASP65 reduces Aβ secretion by elevating non-amyloidogenic cleavage
of the amyloid precursor protein (APP), implicating the Golgi as a potential therapeutic target for AD treatment.
Our overall hypothesis is that Golgi matrix proteins, including GRASPs, organize Golgi membranes into
a stacked structure to ensure the fidelity of protein modification, processing, and sorting. This MIRA
proposal consolidates funded research on two central questions in cell biology concerning Golgi structure and
function: 1) how the stacked Golgi structure is formed, and 2) why Golgi stack formation is important for its
function. We will explore the mechanism of Golgi structure formation by focusing on GRASPs, Golgi matrix and
membrane fusion proteins, as well as their regulation in the cell cycle. We will determine the structure-function
relationship of the Golgi in mitosis when the Golgi stack is completely disassembled, in GRASP-depleted cells
where Golgi cisternae are unstacked, and in cells under stress or disease conditions when the Golgi is
fragmented. In the next 5-10 years, we hope to build a testable model of multiple molecules that form and
maintain the structure of the Golgi while accommodating a variety of trafficking events under physiological and
pathological conditions. Our long-term goal is to develop molecular tools to block Golgi defects in AD patients
and to delay the development of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GOLGI BIOGENESIS AND FUNCTION
-
批准号:10174961
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2019
-
负责人:Yanzhuang Wang
-
依托单位:
GOLGI BIOGENESIS AND FUNCTION
-
批准号:10630831
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2019
-
负责人:Yanzhuang Wang
-
依托单位:
GOLGI BIOGENESIS AND FUNCTION
-
批准号:10417176
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2019
-
负责人:Yanzhuang Wang
-
依托单位:
Supplement: GOLGI BIOGENESIS AND FUNCTION
-
批准号:10794565
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2019
-
负责人:Yanzhuang Wang
-
依托单位:
Supplement: Gogli Biogenesis and Function
-
批准号:10808229
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2019
-
负责人:Yanzhuang Wang
-
依托单位:
GOLGI BIOGENESIS AND FUNCTION
-
批准号:8963053
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2015
-
负责人:Yanzhuang Wang
-
依托单位:
Supplement: GOLGI BIOGENESIS AND FUNCTION
-
批准号:9894924
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2015
-
负责人:Yanzhuang Wang
-
依托单位:
GOLGI BIOGENESIS AND FUNCTION
-
批准号:9116234
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2015
-
负责人:Yanzhuang Wang
-
依托单位:
Ubiquitin and Cell Cycle Regulation of Golgi Membrane Dynamics
-
批准号:8450844
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2009
-
负责人:Yanzhuang Wang
-
依托单位:
Ubiquitin and Cell Cycle Regulation of Golgi Membrane Dynamics
-
批准号:8242103
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2009
-
负责人:Yanzhuang Wang
-
依托单位:
Ubiquitin and Cell Cycle Regulation of Golgi Membrane Dynamics
-
批准号:8047966
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2009
-
负责人:Yanzhuang Wang
-
依托单位:
Ubiquitin and Cell Cycle Regulation of Golgi Membrane Dynamics
-
批准号:7789413
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2009
-
负责人:Yanzhuang Wang
-
依托单位:
海外基金